New insights from the TARGIT A trial 2021

Single-dose radiotherapy

Single-dose radiotherapy for breast cancer confirmed to be suitable for most patients: New insights from the TARGIT-A trial Full paper can be accessed at https://doi.org/10.1038/s41416-021-01… and an invited blog post about it is here https://go.nature.com/3ymrplc Previously published Improving breast cancer treatment: Long-term results of the TARGIT-A randomised trial (www.targit.org.uk) of risk-adapted single-dose TARGIT-IORT given during […]

Read More… from New insights from the TARGIT A trial 2021

Single-dose radiotherapy for breast cancer

Single-dose radiotherapy

Single-dose radiotherapy for breast cancer confirmed to be suitable for most patients: Results from further analysis of the large international TARGIT-A trial led from University College London brings more good news for patients diagnosed with breast cancer. Four important questions have been answered by this new analysis. The new paper can be accessed at https://doi.org/10.1038/s41416-021-01440-8 Previously: […]

Read More… from Single-dose radiotherapy for breast cancer